Migraine in Metabolic Syndrome

Basit Öğe Kaydı
dc.authoridTaşkıran, Bengür/0000-0003-4842-450X
dc.authoridVaran Koc, Gonul/0000-0002-8512-4816
dc.authoridGULDIKEN, Baburhan/0000-0002-9006-1880
dc.authorwosidTaşkıran, Bengür/AAA-3574-2020
dc.authorwosidKoç, Gönül/HPE-0126-2023
dc.contributor.authorGuldiken, Baburhan
dc.contributor.authorGiddiken, Sibel
dc.contributor.authorTaskiran, Bengur
dc.contributor.authorKoc, Gonul
dc.contributor.authorTurgut, Nilda
dc.contributor.authorKabayel, Levent
dc.contributor.authorTugrul, Armagan
dc.date.accessioned2024-06-12T10:59:25Z
dc.date.available2024-06-12T10:59:25Z
dc.date.issued2009
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjectives: Recent studies suggest that insulin resistance is In ore common in patients with migraine. Insulin resistance underlies the pathogenesis of obesity, diabetes. and hypertension that are components of metabolic syndrome. As migraine is associated with an increased risk of vascular disorders, such as stroke. and migraine patients have higher diastolic blood pressure than healthy individuals, we aimed to investigate the I-year prevalence of migraine in metabolic syndrome. Methods: Two hundred ten patients with metabolic syndrome were enrolled in the study. Migraine was diagnosed according to International Classification of Headache Disorders-II criteria. Results: Migraine prevalence was estimated its 11.9% in men and 22.5% in women with metabolic syndrome. Of the metabolic syndrome Components, diabetes, increased waist circumference, and body mass index were significantly more frequent in patients with migraine in contrast to those without migraine (P <0.05). Hypertension and dyslipidemia frequencies showed no difference between 2 groups. Conclusions: Our results demonstrate that migraine prevalence it) metabolic syndrome was higher than in file general population.en_US
dc.identifier.doi10.1097/NRL.0b013e31817781b6
dc.identifier.endpage58en_US
dc.identifier.issn1074-7931
dc.identifier.issue2en_US
dc.identifier.pmid19276782en_US
dc.identifier.scopus2-s2.0-63449123503en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage55en_US
dc.identifier.urihttps://doi.org/10.1097/NRL.0b013e31817781b6
dc.identifier.urihttps://hdl.handle.net/20.500.14551/20440
dc.identifier.volume15en_US
dc.identifier.wosWOS:000264235900002en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofNeurologisten_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDiabetes Mellitusen_US
dc.subjectMetabolic Syndromeen_US
dc.subjectMigraineen_US
dc.subjectObesityen_US
dc.subjectPrevalenceen_US
dc.subjectCoronary-Heart-Diseaseen_US
dc.subjectCardiovascular-Diseaseen_US
dc.subjectInsulin-Resistanceen_US
dc.subjectRisken_US
dc.subjectHeadacheen_US
dc.subjectPrevalenceen_US
dc.subjectStrokeen_US
dc.subjectPopulationen_US
dc.subjectObesityen_US
dc.subjectComorbidityen_US
dc.titleMigraine in Metabolic Syndromeen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu